American Funds (Capital Group) cut its stake in Indegene from 1.42% to 1.31%, selling 2,51,370 shares.
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
India equity holdings of American Funds, the mutual fund family of Capital Group. Long-only, fundamentally driven strategy.
